Metoclopramide Versus Ketorolac for Tension-type Headache
Information source: Montefiore Medical Center
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Headache
Intervention: Metoclopramide (Drug); Ketorolac (Drug)
Phase: Phase 4
Status: Completed
Sponsored by: Montefiore Medical Center
Summary
Occasionally, episodic tension-type headache may be severe enough to require an emergency
department (ED) visit. The purpose of this study is to compare two commonly used medications
to see which is better for tension type headache. Patients who present to the ED with an
acute tension-type headache requiring treatment with injectable medication will be
randomized to metoclopramide or ketorolac.
Clinical Details
Official title: An RCT of Metoclopramide/Diphenhydramine vs. Ketorolac Alone for Tension-type Headache
Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Primary outcome: Change in Pain Score
Secondary outcome: Satisfaction Scores
Eligibility
Minimum age: 21 Years.
Maximum age: 64 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Acute tension type headache
Exclusion Criteria:
- Contraindications to investigational medications
- Secondary cause of headache
Locations and Contacts
Montefiore Medical Center, Bronx, New York 10467, United States
Additional Information
Starting date: November 2009
Last updated: December 5, 2012
|
